{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:33:19Z","timestamp":1781789599346,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.virusres.2021.198657","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T17:40:01Z","timestamp":1639590001000},"page":"198657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Transforming growth factor-\u03b2: An early predictor of a functional cure in chronic hepatitis B treated with interferon"],"prefix":"10.1016","volume":"309","author":[{"given":"Li-Li","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Rong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hua","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Liang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.virusres.2021.198657_bib0001","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00011-016-0921-6","article-title":"TGF-\u03b2 signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment","volume":"65","author":"Argentou","year":"2016","journal-title":"Inflammat. Res.: Off. J. Eur. Histamine Res. Soc."},{"issue":"3","key":"10.1016\/j.virusres.2021.198657_bib0002","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/infdis\/jir283","article-title":"Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients","volume":"204","author":"Chan","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virusres.2021.198657_bib0003","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cgh.2011.08.029","article-title":"Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection","volume":"10","author":"Chen","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol.: Off. Clin. Practice J. Am. Gastroenterol. Assoc."},{"issue":"3","key":"10.1016\/j.virusres.2021.198657_bib0004","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/hep.21726","article-title":"Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA","volume":"46","author":"Chou","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.virusres.2021.198657_bib0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-\u03b2 in progression of liver disease","volume":"347","author":"Dooley","year":"2012","journal-title":"Cell Tissue Res."},{"issue":"12","key":"10.1016\/j.virusres.2021.198657_bib0006","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"TGF-\u03b2 signalling and liver disease","volume":"283","author":"Fabregat","year":"2016","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.virusres.2021.198657_bib0007","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cbin.11022","article-title":"MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-\u03b21\/Smad3 pathway in hepatic stellate cells","volume":"42","author":"Feili","year":"2018","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.virusres.2021.198657_bib0008","first-page":"59","article-title":"Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2","volume":"8","author":"Guo","year":"2009","journal-title":"Hepatobil. Pancreatic Diseas. Int.: HBPD INT"},{"key":"10.1016\/j.virusres.2021.198657_bib0009","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2014.09.011","article-title":"Association of serum IgG N-glycome and transforming growth factor-\u03b21 with hepatitis B virus e antigen seroconversion during entecavir therapy","volume":"111","author":"Ho","year":"2014","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.virusres.2021.198657_bib0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.14218\/JCTH.2017.00072","article-title":"HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B patients with partial response to Nucleos(t)ide analog: new switch study","volume":"6","author":"Hu","year":"2018","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"6","key":"10.1016\/j.virusres.2021.198657_bib0011","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3851\/IMP1866","article-title":"Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside\/nucleotide analogues","volume":"16","author":"Jaroszewicz","year":"2011","journal-title":"Antivir. Ther. (Lond.)"},{"key":"10.1016\/j.virusres.2021.198657_bib0012","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.virusres.2021.198657_bib0013","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1128\/AAC.00249-15","article-title":"Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment","volume":"59","author":"Li","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.virusres.2021.198657_bib0014","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2017-314098","article-title":"Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.virusres.2021.198657_bib0015","first-page":"443","article-title":"Changes in the cytokine profiles of patients with chronic Hepatitis B during antiviral therapy","volume":"34","author":"Li","year":"2021","journal-title":"Biomed. Environ. Sci."},{"issue":"4","key":"10.1016\/j.virusres.2021.198657_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004780","article-title":"TGF-\u03b2 suppression of HBV RNA through AID-dependent recruitment of an RNA exosome complex","volume":"11","author":"Liang","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2021.198657_bib0017","article-title":"Increased proportion of functional subpopulations in circulating regulatory T cells in patients with chronic hepatitis B","author":"Liu","year":"2019","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.virusres.2021.198657_bib0018","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.intimp.2018.06.043","article-title":"Recovery of circulating CD56(dim) NK cells and the balance of Th17\/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg","volume":"62","author":"Liu","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.virusres.2021.198657_bib0019","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12072-012-9343-x","article-title":"Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients","volume":"7","author":"Marcellin","year":"2013","journal-title":"Hepatol. Int."},{"issue":"6","key":"10.1016\/j.virusres.2021.198657_bib0020","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.22265","article-title":"The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells","volume":"47","author":"Mart\u00edn-V\u00edlchez","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2021.198657_bib0021","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3389\/fimmu.2019.03127","article-title":"Advances in targeting the innate and adaptive immune systems to cure chronic Hepatitis B virus infection","volume":"10","author":"Meng","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.virusres.2021.198657_bib0022","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.22744","article-title":"Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients","volume":"49","author":"Moucari","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.virusres.2021.198657_bib0023","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/hep.22765","article-title":"Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B","volume":"49","author":"Murata","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.virusres.2021.198657_bib0024","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jhep.2014.05.044","article-title":"Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: a randomised open-label trial (OSST trial)","volume":"61","author":"Ning","year":"2014","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.virusres.2021.198657_bib0025","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/jvh.13126","article-title":"Roadmap to functional cure of chronic hepatitis B: an expert consensus","volume":"26","author":"Ning","year":"2019","journal-title":"J. Viral Hepat."},{"issue":"10","key":"10.1016\/j.virusres.2021.198657_bib0026","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/apt.15226","article-title":"Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy","volume":"49","author":"Pal","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.virusres.2021.198657_bib0027","doi-asserted-by":"crossref","first-page":"39901","DOI":"10.1038\/srep39901","article-title":"Transforming growth factor \u03b2-activated kinase 1 transcriptionally suppresses hepatitis B virus replication","volume":"7","author":"Pang","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.virusres.2021.198657_bib0028","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1873-3468.12058","article-title":"TGF-\u03b2 triggers HBV cccDNA degradation through AID-dependent deamination","volume":"590","author":"Qiao","year":"2016","journal-title":"FEBS Lett."},{"issue":"10","key":"10.1016\/j.virusres.2021.198657_bib0029","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/apt.14629","article-title":"Systematic review with meta-analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen clearance","volume":"47","author":"Qiu","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.virusres.2021.198657_bib0030","first-page":"545","article-title":"A global scientific strategy to cure hepatitis B. The lancet","volume":"4","author":"Revill","year":"2019","journal-title":"Gastroenterol. Hepatol. (NY)"},{"issue":"10003","key":"10.1016\/j.virusres.2021.198657_bib0031","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.virusres.2021.198657_bib0032","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/hep.25718","article-title":"A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance","volume":"56","author":"Seto","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.virusres.2021.198657_bib0033","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hep.29609","article-title":"Hepatitis B virus sensitivity to interferon-\u03b1 in hepatocytes is more associated with cellular interferon response than with viral genotype","volume":"67","author":"Shen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2021.198657_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2021.198503","article-title":"Identification of plasma lncRNA-ATB levels in hepatitis B virus-related cirrhosis and non-cirrhotic chronic hepatitis B patients","volume":"303","author":"Shoraka","year":"2021","journal-title":"Virus Res."},{"issue":"5","key":"10.1016\/j.virusres.2021.198657_bib0035","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jhep.2013.01.029","article-title":"Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B","volume":"58","author":"Sonneveld","year":"2013","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.virusres.2021.198657_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002594","article-title":"TGF-\u03b21 down-regulation of NKG2D\/DAP10 and 2B4\/SAP expression on human NK cells contributes to HBV persistence","volume":"8","author":"Sun","year":"2012","journal-title":"PLoS Pathog."},{"issue":"17","key":"10.1016\/j.virusres.2021.198657_bib0037","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic Hepatitis B infection: a review","volume":"319","author":"Tang","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.virusres.2021.198657_bib0038","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.virusres.2021.198657_bib0039","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1038\/ctg.2012.17","article-title":"Analysis of notch and TGF-\u03b2 Signaling expression in different stages of disease progression during Hepatitis B virus infection","volume":"3","author":"Trehanpati","year":"2012","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"1","key":"10.1016\/j.virusres.2021.198657_bib0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00535-012-0668-y","article-title":"Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog","volume":"48","author":"Tseng","year":"2013","journal-title":"J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.virusres.2021.198657_bib0041","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.26041","article-title":"Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads","volume":"57","author":"Tseng","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.virusres.2021.198657_bib0042","doi-asserted-by":"crossref","first-page":"14118","DOI":"10.1038\/s41598-019-50729-5","article-title":"Soluble immune markers in the different phases of chronic hepatitis B virus infection","volume":"9","author":"Wiegand","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.virusres.2021.198657_bib0043","first-page":"1116","article-title":"Short hairpin RNA attenuates liver fibrosis by regulating the PPAR\u2011\u03b3 and NF\u2011\u03baB pathways in HBV\u2011induced liver fibrosis in mice","volume":"57","author":"Ye","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.virusres.2021.198657_bib0044","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1172\/JCI118427","article-title":"Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis","volume":"97","author":"Yoo","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.virusres.2021.198657_bib0045","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/jgh.12459","article-title":"Ratios of regulatory T cells\/T-helper 17 cells and transforming growth factor-\u03b21\/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis","volume":"29","author":"Yu","year":"2014","journal-title":"J. Gastroenterol. Hepatol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170221003646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170221003646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:15:05Z","timestamp":1759155305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170221003646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":45,"alternative-id":["S0168170221003646"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2021.198657","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transforming growth factor-\u03b2: An early predictor of a functional cure in chronic hepatitis B treated with interferon","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2021.198657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"198657"}}